Literature DB >> 19098912

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Marjolijn J L Ligtenberg1, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen, Wai Yin Tsui, Chi Kwan Kong, Han G Brunner, Ad Geurts van Kessel, Siu Tsan Yuen, J Han J M van Krieken, Suet Yi Leung, Nicoline Hoogerbrugge.   

Abstract

Lynch syndrome patients are susceptible to colorectal and endometrial cancers owing to inactivating germline mutations in mismatch repair genes, including MSH2 (ref. 1). Here we describe patients from Dutch and Chinese families with MSH2-deficient tumors carrying heterozygous germline deletions of the last exons of TACSTD1, a gene directly upstream of MSH2 encoding Ep-CAM. Due to these deletions, transcription of TACSTD1 extends into MSH2. The MSH2 promoter in cis with the deletion is methylated in Ep-CAM positive but not in Ep-CAM negative normal tissues, thus revealing a correlation between activity of the mutated TACSTD1 allele and epigenetic inactivation of the corresponding MSH2 allele. Gene silencing by transcriptional read-through of a neighboring gene in either sense, as demonstrated here, or antisense direction, could represent a general mutational mechanism. Depending on the expression pattern of the neighboring gene that lacks its normal polyadenylation signal, this may cause either generalized or mosaic patterns of epigenetic inactivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098912     DOI: 10.1038/ng.283

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  24 in total

Review 1.  New perspectives on connecting messenger RNA 3' end formation to transcription.

Authors:  Nick Proudfoot
Journal:  Curr Opin Cell Biol       Date:  2004-06       Impact factor: 8.382

2.  Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).

Authors:  Heleen van der Klift; Juul Wijnen; Anja Wagner; Paul Verkuilen; Carli Tops; Robyn Otway; Maija Kohonen-Corish; Hans Vasen; Cristina Oliani; Daniela Barana; Pal Moller; Celia Delozier-Blanchet; Pierre Hutter; William Foulkes; Henry Lynch; John Burn; Gabriela Möslein; Riccardo Fodde
Journal:  Genes Chromosomes Cancer       Date:  2005-10       Impact factor: 5.006

3.  Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

Authors:  M F Kane; M Loda; G M Gaida; J Lipman; R Mishra; H Goldman; J M Jessup; R Kolodner
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

4.  Promoter analysis of the human mismatch repair gene hMSH2.

Authors:  Y Iwahashi; E Ito; Y Yanagisawa; Y Akiyama; Y Yuasa; T Onodera; K Maruyama
Journal:  Gene       Date:  1998-06-15       Impact factor: 3.688

5.  A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor.

Authors:  Isabella Gazzoli; Massimo Loda; Judy Garber; Sapna Syngal; Richard D Kolodner
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

6.  Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease.

Authors:  Cristina Tufarelli; Jackie A Sloane Stanley; David Garrick; Jackie A Sharpe; Helena Ayyub; William G Wood; Douglas R Higgs
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

Review 7.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

Authors:  Manon J Winter; Iris D Nagtegaal; J Han J M van Krieken; Sergey V Litvinov
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas.

Authors:  Judith W M Jeuken; Sandra J B Cornelissen; Martine Vriezen; Marieke M G Dekkers; Abdellatif Errami; Angelique Sijben; Sandra H E Boots-Sprenger; Pieter Wesseling
Journal:  Lab Invest       Date:  2007-08-13       Impact factor: 5.662

9.  Germline epimutation of MLH1 in individuals with multiple cancers.

Authors:  Catherine M Suter; David I K Martin; Robyn L Ward
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

10.  Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

Authors:  Wenqiang Yu; David Gius; Patrick Onyango; Kristi Muldoon-Jacobs; Judith Karp; Andrew P Feinberg; Hengmi Cui
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

View more
  262 in total

1.  How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Authors:  Kristen K Ciombor; Sigurdis Haraldsdottir; Richard M Goldberg
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

2.  The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program.

Authors:  Aparna Mukherjee; Thomas J McGarrity; Francesca Ruggiero; Walter Koltun; Kevin McKenna; Lisa Poritz; Maria J Baker
Journal:  Hered Cancer Clin Pract       Date:  2010-11-22       Impact factor: 2.857

3.  Micromanaging the classification of colon cancer: the role of the microRNAome.

Authors:  Eduardo Vilar; Josep Tabernero; Stephen B Gruber
Journal:  Clin Cancer Res       Date:  2011-10-21       Impact factor: 12.531

4.  Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.

Authors:  Scott M Weissman; Randall Burt; James Church; Steve Erdman; Heather Hampel; Spring Holter; Kory Jasperson; Matt F Kalady; Joy Larsen Haidle; Henry T Lynch; Selvi Palaniappan; Paul E Wise; Leigha Senter
Journal:  J Genet Couns       Date:  2011-12-14       Impact factor: 2.537

Review 5.  Understanding transgenerational epigenetic inheritance via the gametes in mammals.

Authors:  Lucia Daxinger; Emma Whitelaw
Journal:  Nat Rev Genet       Date:  2012-01-31       Impact factor: 53.242

Review 6.  Lynch syndrome diagnostics: decision-making process for germ-line testing.

Authors:  E Lastra; M García-González; B Llorente; C Bernuy; M J Barrio; L Pérez-Cabornero; M Durán; C García-Girón
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

Review 7.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 8.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

9.  EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients.

Authors:  Carla Guarinos; Adela Castillejo; Víctor-Manuel Barberá; Lucía Pérez-Carbonell; Ana-Beatriz Sánchez-Heras; Angel Segura; Carmen Guillén-Ponce; Ana Martínez-Cantó; María-Isabel Castillejo; Cecilia-Magdalena Egoavil; Rodrigo Jover; Artemio Payá; Cristina Alenda; José-Luís Soto
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

Review 10.  New genes emerging for colorectal cancer predisposition.

Authors:  Clara Esteban-Jurado; Pilar Garre; Maria Vila; Juan José Lozano; Anna Pristoupilova; Sergi Beltrán; Anna Abulí; Jenifer Muñoz; Francesc Balaguer; Teresa Ocaña; Antoni Castells; Josep M Piqué; Angel Carracedo; Clara Ruiz-Ponte; Xavier Bessa; Montserrat Andreu; Luis Bujanda; Trinidad Caldés; Sergi Castellví-Bel
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.